August 13, 2024 C-Path’s TRxA Announces $250,000 Grant for Drug Development Project on Antibiotic-Resistant Gram-Negative Bacteria TUCSON, Ariz. August 13, 2024– Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced toda
August 12, 2024 C-Path Welcomes CuraSen As Newest CPP Member C-Path is thrilled to welcome CuraSen Therapeutics as the newest member of its Critical Path for Parkinson’s Consortium.
August 8, 2024 C-Path’s TRxA Announces $250,000 Award for Drug Development Project in ALS TUCSON, Ariz., August 8, 2024 – Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced tod
August 6, 2024 C-Path Welcomes New Advisory Members to Alpha-1 Antitrypsin Deficiency Consortium C-Path's Critical Path for Alpha-1 Antitrypsin Deficiency (CPA-1) consortium today announced the addition of several...
July 31, 2024 Meet the Team — Q&A with Clinical Outcome Assessment Scientist Cole Ayasse I am a Clinical Outcome Assessment (COA) Scientist in the COA Program at C-Path.
July 26, 2024 C-Path’s Alzheimer’s Consortium Unveils Seminal Methodology to Enhance Alzheimer’s Clinical Trials Using Imaging Biomarkers C-Path is proud to announce the publication of a new study in the journal Alzheimer’s & Dementia...
June 24, 2024-June 25, 2024 C-Path’s Stephenson to Serve as Co-panelist for FNIH Digital Technologies Summit C-Path's Executive Director, Critical Path for Parkinson's (CPP) Consortium, Diane Stephenson will join as a...
June 20, 2024 C-Path Partners with FARA to Fortify RDCA-DAP and Further Accelerate Drug Development with new Friedreich’s Ataxia Data C-Path announced the targeted integration of additional Friedreich’s ataxia...
June 20, 2024 C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development C-Path, a leader in forming collaborations that accelerate drug development, and Centogene N.V. (Nasdaq: CNTG)...
June 12, 2024 C-Path’s Parkinson’s Consortium Supports Groundbreaking Research Utilizing Smartwatches to Monitor Disease Progression Critical Path Institute (C-Path) today announced a new publication on how the use of wearable technology...
